Wright Investors Service Inc Vertex Pharmaceuticals Inc Transaction History

Wright Investors Service Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$392.81 - $485.53 $3,142 - $3,884	-8 Reduced 0.24%	3,373 $1.58 Million
Q1 2024 May 02, 2024	BUY	$407.69 - $446.08 $799,072 - $874,316	1,960 Added 137.93%	3,381 $1.41 Million
Q4 2023 Jan 31, 2024	BUY	$343.0 - $410.68 $487,403 - $583,576	1,421 New	1,421 $578,000
Q2 2022 Aug 02, 2022	SELL	$234.96 - $292.55 $351,735 - $437,947	-1,497 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$221.42 - $260.97 $331,465 - $390,672	1,497 New	1,497 $391,000
Q2 2021 Aug 03, 2021	SELL	$187.49 - $221.1 $777,896 - $917,343	-4,149 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$207.02 - $241.31 $562,887 - $656,121	2,719 Added 190.14%	4,149 $892,000
Q4 2020 Feb 02, 2021	BUY	$207.01 - $276.09 $296,024 - $394,808	1,430 New	1,430 $338,000

1,722

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Wright Investors Service Inc, based on Form 13F filings with the SEC.

Stay updated on Wright Investors Service Inc with notifications on news.